Publication: A Rapid Stability Indicating HPLC Method for Determination of Quetiapine Fumarate in Tablets and Extemporaneous Formulations
5
Issued Date
2021-11-01
Resource Type
ISSN
15739031
0091150X
0091150X
Other identifier(s)
2-s2.0-85120160931
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Pharmaceutical Chemistry Journal. Vol.55, No.8 (2021), 845-854
Suggested Citation
Nantana Nuchtavorn, Jiraporn Leanpolchareanchai, Duangjai Chanton, Patcharin Supapsophon, Sumet Chongruchiroj, Jidapa Chatmapanrangsee, Jiraphong Suksiriworapong A Rapid Stability Indicating HPLC Method for Determination of Quetiapine Fumarate in Tablets and Extemporaneous Formulations. Pharmaceutical Chemistry Journal. Vol.55, No.8 (2021), 845-854. doi:10.1007/s11094-021-02505-x Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/78937
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
A Rapid Stability Indicating HPLC Method for Determination of Quetiapine Fumarate in Tablets and Extemporaneous Formulations
Other Contributor(s)
Abstract
Quetiapine fumarate is an atypical antipsychotic drug, which is clinically used for the treatment of depression and bipolar disorders. A stability indicating method is required for the quality control of pharmaceutical dosage forms. This work focused on the developments of a rapid stability indicating reversed-phase HPLC-UV method for determination of quetiapine fumarate in tablets and extemporaneous formulations. Quetiapine fumarate was simultaneously determined in the presence of three impurities: quetiapine related compound B, quetiapine related compound G, and quetiapine N-oxide within 9 min. Optimal HPLC conditions were realized using Zorbax C8 column (100 mm × 4.6 cm i.d., 3 μm particle). Gradient elution utilized mobile composition of 0.15% triethylamine (pH 6.0) and acetonitrile : methanol (80:20) mixture at a flow rate of 1.2 mL/min with detection wavelength at 252 nm. The proposed method showed good linearity (r2 > 0.998), precision (RSDs ≤ 2.2), and accuracy (%recovery 96.8 – 99.4, RSD ≤ 1.9) with acceptable limits of detection (LOD ≤ 3.0 μg/mL) and quantitation (LOQ ≤ 10 μg/mL) at RSD ≤ 2.8). The method was successfully applied to the determination of quetiapine fumarate in pharmaceutical formulations and stability testing of extemporaneous formulations.